X2 Project

X2 Project

May 05 2008 | comment(s)

I was asked by the Institute for the Future to highlight a dozen "Signals" that may point to new trends in science as part of the X2 Project:
Today, science is entering another period of accelerated change, thanks to the growth of the Internet and dawn of pervasive computing; the explosive growth of new sciences like genetic engineering, nanotechnology, biotechnology, and simulation; the rise of new scientific powers in the developing world, the revival of amateur scientists, and the growth of citizen science movements in the United States and Europe; the growth of new institutions supporting scientific research and innovation, and changes in the structure and funding of universities, government, an

WICHITA, Kansas, May 5 /PRNewswire/ --

Spirit AeroSystems, Inc. (NYSE: SPR) President and Chief Executive Officer Jeff Turner will speak at the Bank of America 2008 BASics/Industrials Conference on Thursday, May 8, at approximately 10:40 a.m. Eastern Time.

Turner's remarks will be webcast at http://www.spiritaero.com/investor.aspx. Individuals are advised to check the web site ahead of time to ensure their computers are configured for the webcast.

Web site: http://www.spiritaero.com/investor.aspx

Philip Anderson, Investor Relations of Spirit AeroSystems, Inc., +1-316-523-1797

SAN DIEGO, May 5 /PRNewswire/ --

- Study represents first inclusion of Volcano Revolution(R) 45 MHz IVUS Imaging Catheter in large-scale pharmaceutical plaque progression trial.

Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today participation in SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN). This marks the first major pharmaceutical trial allowing physicians to use the Volcano Revolution(R) 45 MHz IVUS Imaging catheter as part of the protocol.

BOSTON, May 5 /PRNewswire/ --

Eagle Investment Systems LLC, a leading provider of financial services technology and a subsidiary of The Bank of New York Mellon, has welcomed approximately 400 attendees, a record attendance, at its 2008 Client Conference being held at The Breakers in Palm Beach, Florida from May 4 -- 7.

Not long ago, Howard Wainer, a statistician I mentioned recently, learned that his blood sugar was too high. His doctor told him to lose weight or risk losing his sight. He quickly lost about 50 pounds, which put him below 200 pounds. He also started making frequent measurements of his blood sugar, on the order of 6 times per day, with the goal of keeping it low.

It was obvious to him that the conventional (meter-supplied) analysis of these measurements could be improved. The conventional analysis emphasized means. You could get the mean of your last n (20?) readings, for example. That told you how well you were doing, but didn’t help you do better.

Howard, who had written a book about graphical discovery, made a graph: blood sugar versus time. It showed that his measurements could be divided into three parts:

CALGARY, Canada, May 5 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2008 Annual and Special Meeting of the Shareholders will be held on Wednesday, May 7, 2008 at 9:00 a.m. (ET) at the Yale Club of New York City, 50 Vanderbilt Ave, New York.

Following the business portion of the meeting, Dr. Brad Thompson, President and CEO of Oncolytics, will discuss recent progress in developing REOLYSIN(R) as a potential cancer therapeutic.

LONDON, May 5 /PRNewswire/ -- BCS Global Networks is pleased to announce that Clive Sawkins has accepted the position as Chief Executive Officer of the company. BCS is a managed service provider enabling video conferencing and visual collaboration globally. With its global video infrastructure, BCS provides its customers with an easy to use; direct connect, visual link to customers, colleagues and experts around the world.

Whole-organ maps that superimpose genetic information over the terrain of cancerous bladders chart the molecular journey from normal cell to invasive cancer, an international research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports online ain Laboratory Investigation.

By geographically relating an organ’s varied tissues – normal, precancerous and malignant – to their underlying genetic variation or regulation, the team also identified a crucial new category of genes that launches the process of cancer development.

“These ‘forerunner genes’ are the ignition key that starts the engine of carcinogenesis,” said senior author Bogdan Czerniak, M.D., Ph.D., professor in M. D. Anderson’s Department of Pathology.

Want to live a long life? Your genes still don't make a difference (yet) according to research on the bone health of one of the oldest persons in the world who recently died at the age of 114 The study reveals that there were no genetic modifications which could have contributed to this longevity.

The research team, directed by Universitat Autònoma de Barcelona professor Adolfo Díez Pérez, pointed out a healthy lifestyle, a Mediterranean diet, a temperate climate and regular physical activity as the reasons for his excellent health.

They studied the bone mass and analysed the genetics of a man with enviable health who at the time of the study was 113 years old. The research was carried out with four other members of his family: a 101-year-old brother, two daughters aged 81 and 77, and a nephew aged 85, all of them born and still living in a small town of the island of Menorca. The man's bones were in excellent conditions: his bone mass was normal, there were no anomalous curvatures and he had never sustained a fracture.

Scientists at Gramina, a joint biotech venture by Australia’s Molecular Plant Breeding Cooperative Research Centre and New Zealand rural services group PGG Wrightson Genomics, are developing a grass that will not only cut the amount of methane cows burp up when chewing the cud but will also grow in hotter climes, according to the latest issue of Chemistry & Industry.

This means that farmers should be able to maintain dairy herds’ productivity and profitability in the face of a changing climate, while cutting down their gaseous burps and reducing their contribution to global warming.

Combating greenhouse gas emissions produced by the agricultural industry is a priority. The UK’s DEFRA has just announced a roadmap aimed at helping the dairy industry reduce its potential impact on the environment in line with Britain’s target to cut its greenhouse emissions by 20% by 2010. By 2015 the roadmap plans to have 20-30% of milk producers trialling new technology to cut greenhouse gas emissions.